Pten, tumorigenesis, and stem cell self-renewal

Cell
Derrick J Rossi, Irving L Weissman

Abstract

Self-renewal pathways crucial for maintaining stem cells are deregulated in cancer, raising the spectre that cancer therapies targeting such pathways might also ablate normal stem cells. As Yilmaz et al. (2006) report in a recent Nature paper, this may not be the case for the tumor suppressor protein Pten, which drives the self-renewal of normal hematopoietic stem cells and the formation of leukemia cells through different mechanisms.

References

Dec 1, 2001·Science·D E WrightI L Weissman
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Sep 22, 2005·JAMA : the Journal of the American Medical Association·Irving Weissman

❮ Previous
Next ❯

Citations

Jan 1, 2010·Cell Death & Disease·R R Ruela-de-SousaM P Peppelenbosch
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Matthias P Wymann, Roger Schneiter
May 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·Tatsuki KurokawaYasushi Okamura
Oct 26, 2007·Molecular Biology of the Cell·Carmen SegrellesJesús M Paramio
Oct 4, 2008·Journal of Immunotherapy·Anna Karolina PaluckaJacques Banchereau
Aug 26, 2010·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Natsumi IraharaShuji Ogino
Dec 17, 2009·Genes & Development·Virginie OliveLin He
Jul 25, 2007·Annual Review of Cell and Developmental Biology·Neethan A LoboMichael F Clarke
May 12, 2010·The Journal of Clinical Investigation·Alexey BersenevWei Tong
Aug 6, 2009·BMC Cancer·Jingmei LiuZhiyuan Shen
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madhuri Kakarala, Max S Wicha
Dec 3, 2008·Disease Models & Mechanisms·Néstor J OviedoAlejandro Sánchez Alvarado
Sep 11, 2007·Biological & Pharmaceutical Bulletin·Tomohiko Maehama
Jun 24, 2014·Genomics, Proteomics & Bioinformatics·Wei XuSongnian Hu
Jun 19, 2008·Stem Cell Reviews·C R A RegenbrechtJ Adjaye
Mar 20, 2010·Cellular and Molecular Life Sciences : CMLS·Gaoliang OuyangChaoyong James Yang
Nov 30, 2006·Current Opinion in Oncology·Muhammad Al-Hajj
Nov 26, 2015·International Journal of Molecular Sciences·Dagmara JaworskaEwelina Szliszka
Mar 23, 2010·The Journal of Urology·Kyung-Mi BaeDietmar W Siemann
Feb 27, 2010·Experimental Cell Research·Yingbin YangK L Paul Sung
Nov 21, 2007·Current Opinion in Biotechnology·Laurie E Ailles, Irving L Weissman
Nov 11, 2008·European Journal of Immunology·Ling XueAstar Winoto
Nov 22, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jiman HeJack R Wands
Jan 29, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Nury KimYong-Mahn Han
Mar 22, 2016·The Spine Journal : Official Journal of the North American Spine Society·Ching-Hua YehXudong Joshua Li
Nov 1, 2007·Izvestiia Akademii nauk. Seriia biologicheskaia·N D Ozerniuk, O V Balan
Nov 6, 2007·Immunological Reviews·A Karolina PaluckaJacques Banchereau
Feb 10, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ayelet VoskoboynikIrving L Weissman

❮ Previous
Next ❯

Related Concepts

Related Feeds

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.